Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0000921895-24-000666
Filing Date
2024-03-15
Accepted
2024-03-15 16:31:36
Documents
2

Document Format Files

Seq Description Document Type Size
1 sc13g10022bio_03152024.htm SC 13G 215316
2 ex991to13g10022bio_03152024.htm EX-99.1 12233
  Complete submission text file 0000921895-24-000666.txt   229112
Mailing Address 120 PRESIDENTIAL WAY, SUITE 330 WOBURN MA 01801
Business Address 120 PRESIDENTIAL WAY, SUITE 330 WOBURN MA 01801 781-245-1325
Biofrontera Inc. (Subject) CIK: 0001858685 (see all company filings)

EIN.: 473765675 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-93395 | Film No.: 24755319
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 11700 W CHARLESTON BLVD 170-659 LAS VEGAS NV 89135
Business Address 11700 W CHARLESTON BLVD 170-659 LAS VEGAS NV 89135 631-987-0235
Bigger Capital, LLC (Filed by) CIK: 0001996245 (see all company filings)

EIN.: 900131168 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G